Dow, S&P 500 Jump on Soft Inflation Readout
Digest more
7h
Stock market today: Dow, S&P 500, Nasdaq rise as CPI inflation eases in November, Micron boosts tech
Stocks jumped following the latest reading on consumer inflation that could help set expectations for the path of interest rates.
Major stock indexes surged Thursday after delayed Consumer Price Index data came in better than expected, with the blue-chip Dow Jones Industrial Average and benchmark S&P 500 poised to end four-session losing streaks.
Barchart on MSN
Is Hasbro Stock Outperforming the Dow?
As Hasbro has outperformed relative to the Dow over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Shares of FactSet Research Systems Inc. shed 7.68% to $273.39 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.79% to 6,774.
Major stock indexes fell Wednesday, with the S&P 500 and Dow Jones Industrial Average on pace for a fourth consecutive decline, as AI bubble concerns resumed and investors digested tepid labor data.
U.S. stocks rose following an encouraging report on inflation that could help the Federal Reserve keep cutting interest rates next year.
Stocks could see wild swings in the last trading push of the year. Where to put your money. Investors are dumping stock-market winners and buying almost everything else. Why that’s a good sign.
24/7 Wall St. on MSN
These 3 Boring Stocks Are Delivering the Dow’s Biggest Wins in 2025
As 2025 draws to a close, the Dow Jones Industrial Average (DJIA) is having a superb year, up nearly 13% year to date. While artificial intelligence (AI)-oriented stocks continue to dominate headlines,
Investor's Business Daily on MSN
Stock market today: Dow slides, Nasdaq positive after jobs data; Nvidia rises (live coverage)
In the apparel-clothing stocks group, Gildan Activewear GIL also broke out of a cup base with a buy point of 62.56 before retreating. The blue dot on its chart on IBD MarketSurge shows that its relative strength line is at a new high. Shares were up nearly 4% in recent action.
Cybin is rebranding itself as Helus Pharma and moving its stock listing to Nasdaq from the New York Stock Exchange. The pharmaceutical company said Thursday that its stock will trade on Nasdaq under the ticker HELP. The stock will stop trading on NYSE at the end of business on Jan. 5, 2026, and begin trading on Nasdaq the following morning.
Feedback